Tekmira Pharmaceuticals Corporation
Patents = 14
Forward Citations = 1,099
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
65 inventors (with patents filed for the assignee):
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing innovative RNA interference (RNAi) therapeutics and delivery solutions. With its proprietary lipid nanoparticle (LNP) technology, Tekmira is dedicated to developing and commercializing RNAi-based treatments for a wide range of diseases, including cancer, viral infections, and rare genetic disorders.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com